Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 372–372 | Cite as

Natalizumab

Tumefactive demyelinating lesions: case report
Case report
  • 18 Downloads

Reference

  1. Moghadasi AN, et al. Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab. Acta Neurologica Belgica 119: 137-139, No. 1, 12 Mar 2019. Available from: URL: http://doi.org/10.1007/s13760-018-0948-2 - Iran

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations